393 POSTER First-in-man Phase I trial of BYK408740, an oral histone deacetylase inhibitor, in patients with advanced malignancies
J.E. Ang, B. Hauns, A. Mais, A. Parker, R. Lal, D. Olmos, M. Mollenhauer, A. Walz, J.S. de BonoVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72327-9
File:
PDF, 76 KB
english, 2008